Investor's Business Daily on MSN
Exelixis earns IBD stock rating upgrade
The IBD SmartSelect Composite Rating for Exelixis rose from 94 to 96 Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results